Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Complete Genomics, Soon to Be a BGI Subsidiary, Wins Partial Victory in Illumina Suit

publication date: Oct 19, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Complete Genomics, the California sequencing company, gained a partial victory in Illumina’s patent suit against the company. The judge rejected Claim 1 of the suit, ruling that prior art shows Illumina’s technology was not novel. In September, BGI, the giant sequencing company headquartered in Shenzhen, announced it would buy Complete Genomics for $127 million. More details....

Stock Symbols: (NSDQ: GNOM) (NSDQ: ILMN)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners